Parallax Volatility Advisers’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
EC
BCM
BG
Parallax Volatility Advisers's TNDM Position: Q2 2021 in Review
Parallax Volatility Advisers sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 232 shares — an estimated $20K sold.
Parallax Volatility Advisers first reported a position in TNDM in Q3 2018 and held it in 10 quarters. The position peaked at $3.83M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.
- Parallax Volatility Advisers reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
- Parallax Volatility Advisers sold 232 Tandem Diabetes Care shares in Q2 2021, an estimated $20K.
- Parallax Volatility Advisers first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 10 quarters.
- Parallax Volatility Advisers's Tandem Diabetes Care position peaked at $3.83M in Q3 2020.
- 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.
Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.